======= USP47 ======= == Gene Information == * **Official Symbol**: USP47 * **Official Name**: ubiquitin specific peptidase 47 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=55031|55031]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q96K76|Q96K76]] * **Interactions**: [[https://thebiogrid.org/search.php?search=USP47&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20USP47|Open PubMed]] * **OMIM**: [[https://omim.org/entry/614460|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Ubiquitin-specific protease that specifically deubiquitinates monoubiquitinated DNA polymerase beta (POLB), stabilizing POLB thereby playing a role in base-excision repair (BER). Acts as a regulator of cell growth and genome integrity. May also indirectly regulate CDC25A expression at a transcriptional level. {ECO:0000269|PubMed:19966869, ECO:0000269|PubMed:21362556}. |UCH| |WD40-repeat domain binding| |ubiquitinyl hydrolase activity| |monoubiquitinated protein deubiquitination| |negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage| |base-excision repair| |regulation of intrinsic apoptotic signaling pathway in response to DNA damage| |thiol-dependent ubiquitinyl hydrolase activity| |SCF ubiquitin ligase complex| |negative regulation of response to DNA damage stimulus| |negative regulation of cysteine-type endopeptidase activity involved in apoptotic process| |cellular response to UV| |negative regulation of G2/M transition of mitotic cell cycle| |negative regulation of cysteine-type endopeptidase activity| |cysteine-type endopeptidase activity| |negative regulation of intrinsic apoptotic signaling pathway| |negative regulation of cell cycle G2/M phase transition| |thiol-dependent ubiquitin-specific protease activity| |cellular response to light stimulus| |response to UV| |positive regulation of canonical Wnt signaling pathway| |regulation of intrinsic apoptotic signaling pathway| |positive regulation of cell growth| |cellular response to radiation| |positive regulation of Wnt signaling pathway| |regulation of G2/M transition of mitotic cell cycle| |regulation of cell cycle G2/M phase transition| |negative regulation of mitotic cell cycle phase transition| |regulation of cysteine-type endopeptidase activity involved in apoptotic process| |regulation of response to DNA damage stimulus| |negative regulation of apoptotic signaling pathway| |negative regulation of cell cycle phase transition| |regulation of cysteine-type endopeptidase activity| |negative regulation of endopeptidase activity| |negative regulation of peptidase activity| |positive regulation of growth| |regulation of canonical Wnt signaling pathway| |protein deubiquitination| |regulation of protein stability| |protein modification by small protein removal| |negative regulation of mitotic cell cycle| |response to light stimulus| |cellular response to environmental stimulus| |cellular response to abiotic stimulus| |negative regulation of cell cycle process| |negative regulation of proteolysis| |regulation of Wnt signaling pathway| |regulation of apoptotic signaling pathway| |regulation of mitotic cell cycle phase transition| |regulation of endopeptidase activity| |regulation of cell growth| |response to radiation| |regulation of peptidase activity| |regulation of cell cycle phase transition| |negative regulation of hydrolase activity| |negative regulation of intracellular signal transduction| |DNA repair| |ubiquitin-dependent protein catabolic process| |modification-dependent protein catabolic process| |modification-dependent macromolecule catabolic process| |negative regulation of cell cycle| |proteolysis involved in cellular protein catabolic process| |cellular protein catabolic process| |regulation of mitotic cell cycle| |regulation of growth| |protein catabolic process| |regulation of proteolysis| |regulation of cellular response to stress| |DNA metabolic process| |regulation of cell cycle process| |cellular response to DNA damage stimulus| |negative regulation of catalytic activity| |negative regulation of apoptotic process| |negative regulation of programmed cell death| |cellular macromolecule catabolic process| |protein modification by small protein conjugation or removal| |negative regulation of cell death| |response to drug| |negative regulation of cellular protein metabolic process| |macromolecule catabolic process| |organonitrogen compound catabolic process| |negative regulation of protein metabolic process| |negative regulation of molecular function| |response to abiotic stimulus| |regulation of cell cycle| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of signal transduction| |proteolysis| |regulation of hydrolase activity| |negative regulation of RNA metabolic process| |negative regulation of cell communication| |negative regulation of signaling| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |regulation of response to stress| |negative regulation of cellular biosynthetic process| |regulation of apoptotic process| |negative regulation of biosynthetic process| |regulation of programmed cell death| |negative regulation of response to stimulus| |positive regulation of signal transduction| |regulation of cell death| |cellular response to stress| |negative regulation of gene expression| |organic substance catabolic process| |cellular catabolic process| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp24|Nocodazole 0.2μM R00 exp24]]|-1.72| |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|1.98| ^Gene^Correlation^ |[[:human genes:g:golga6l1|GOLGA6L1]]|0.433| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 8143 * **Expression level (log2 read counts)**: 6.76 {{:chemogenomics:nalm6 dist.png?nolink |}}